Regentis Biomaterials Ltd. (RGNT) is a publicly traded the market company. As of November 9, 2026, RGNT trades at $1.49 with a market cap of $8.36M and a P/E ratio of 0.00. RGNT moved +19.33% today. Year to date, RGNT is -82.11%; over the trailing twelve months it is flat. Its 52-week range spans $1.16 to $15.50. Rallies surfaces RGNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $8.36M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.50 |
| 52-Week Low | $1.16 |
| Volume | 52.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
RGNT analyst coverage data. Average price target: $0.00.